HK52990A - 4-aryl-1, -4- dihydropyridine-3, 5- dicaboxylate derivatives - Google Patents

4-aryl-1, -4- dihydropyridine-3, 5- dicaboxylate derivatives Download PDF

Info

Publication number
HK52990A
HK52990A HK529/90A HK52990A HK52990A HK 52990 A HK52990 A HK 52990A HK 529/90 A HK529/90 A HK 529/90A HK 52990 A HK52990 A HK 52990A HK 52990 A HK52990 A HK 52990A
Authority
HK
Hong Kong
Prior art keywords
dicaboxylate
dihydropyridine
aryl
derivatives
alkyl
Prior art date
Application number
HK529/90A
Other languages
English (en)
Inventor
Semeraro Claudio
Michell Dino
Pieraccioll Daniele
Gaviraghi Giovanni
David Borthwick Allan
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT22383/84A external-priority patent/IT1175620B/it
Priority claimed from IT21460/85A external-priority patent/IT1187678B/it
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of HK52990A publication Critical patent/HK52990A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2205/00—Fibre drawing or extruding details
    • C03B2205/44—Monotoring or regulating the preform feed rate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK529/90A 1984-08-22 1990-07-12 4-aryl-1, -4- dihydropyridine-3, 5- dicaboxylate derivatives HK52990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22383/84A IT1175620B (it) 1984-08-22 1984-08-22 Derivati piridinici
IT21460/85A IT1187678B (it) 1985-07-05 1985-07-05 Procedimento di preparazione di derivati eterociclici

Publications (1)

Publication Number Publication Date
HK52990A true HK52990A (en) 1990-07-20

Family

ID=26327905

Family Applications (1)

Application Number Title Priority Date Filing Date
HK529/90A HK52990A (en) 1984-08-22 1990-07-12 4-aryl-1, -4- dihydropyridine-3, 5- dicaboxylate derivatives

Country Status (33)

Country Link
US (2) US4801599A (fr)
JP (2) JPS6193162A (fr)
KR (1) KR920004482B1 (fr)
AT (1) AT394042B (fr)
AU (1) AU578724B2 (fr)
BE (1) BE903103A (fr)
BG (1) BG60409B2 (fr)
CA (1) CA1268180A (fr)
CH (1) CH666684A5 (fr)
CS (1) CS403091A3 (fr)
CY (1) CY1494A (fr)
DE (1) DE3529997C2 (fr)
DK (1) DK165949C (fr)
ES (5) ES8703839A1 (fr)
FI (1) FI81568C (fr)
FR (1) FR2569402B1 (fr)
GB (1) GB2164336B (fr)
GR (1) GR852016B (fr)
HK (1) HK52990A (fr)
HU (1) HU196754B (fr)
IE (1) IE58486B1 (fr)
LU (2) LU88267I2 (fr)
MX (1) MX159974A (fr)
NL (2) NL193065C (fr)
NO (2) NO167142C (fr)
NZ (1) NZ212895A (fr)
PH (1) PH22014A (fr)
PT (1) PT81000B (fr)
SA (1) SA91120277B1 (fr)
SE (1) SE459920B (fr)
SG (1) SG40889G (fr)
SK (1) SK278327B6 (fr)
ZW (1) ZW13185A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3675747D1 (de) * 1985-08-21 1991-01-03 Glaxo Spa 1,4-dihydropyridinverbindungen und ihre herstellung und pharmazeutische formulierung.
CH669788A5 (fr) * 1985-08-21 1989-04-14 Glaxo Spa
IT1204461B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204460B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204462B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1233370B (it) * 1988-11-21 1992-03-27 Glaxo Spa Procedimento di preparazione di derivati diidropipiridinici utili nel trattamento di disturbi cardiovascolari
EP0395369B1 (fr) 1989-04-27 1997-07-02 Canon Inc. Milieu d'enregistrement optique et son procédé de fabrication
US5196529A (en) * 1990-10-09 1993-03-23 Merck & Co., Inc. 2-phenanthrenyl carbapenem intermediates
US5177202A (en) * 1990-10-09 1993-01-05 Merck & Co., Inc. 2-phenanthrenyl-carbapenems
US5132421A (en) * 1990-10-09 1992-07-21 Merck & Co., Inc. 2-naphthyl-carbapenem intermediates
US5132422A (en) * 1990-10-09 1992-07-21 Merck & Co., Inc. 2-naphthyl-carbapenem intermediates
US5144028A (en) * 1990-10-09 1992-09-01 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem intermediates
US5356889A (en) * 1990-08-01 1994-10-18 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem intermediates
US5208329A (en) * 1990-10-09 1993-05-04 Merck & Co., Inc. 2-biphenyl carbapenem intermediates
IT1244728B (it) * 1991-02-13 1994-08-08 Glaxo Spa Impiego medicamentoso di derivati diidropiridinici
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
WO2000027397A1 (fr) * 1998-11-06 2000-05-18 Glaxo Group Limited Medicaments antihypertenseurs a base de lacidipine et de telmisartan
CA2495962A1 (fr) 2002-08-19 2004-03-04 Pfizer Products Inc. Therapie de combinaison pour maladies hyperproliferatives
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
MX2007000979A (es) * 2004-07-26 2007-07-11 Cotherix Inc Tratamiento de la hipertension pulmonar por iloprost inhalado con una formulacion microparticulada.
WO2006113309A1 (fr) 2005-04-15 2006-10-26 Dr. Reddy's Laboratories Ltd. Particules de lacidipine
US20070043088A1 (en) * 2005-08-16 2007-02-22 Eswaraiah Sajja Process for preparing lacidipine
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP1951253A2 (fr) 2005-10-26 2008-08-06 Cotherix, Inc. Fasudil en polytherapies pour traiter l'hypertension arterielle pulmonaire
EP2351569B1 (fr) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil dans des thérapies combinées pour le traitement de l'hypertension artérielle pulmonaire
CA2627599A1 (fr) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Procede de preparation de sel hemicalcique d'acide (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxymethylphenylamino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoique
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008020314A2 (fr) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Formulations de dosage stabilisantes à base de statine
US20080153896A1 (en) * 2006-07-14 2008-06-26 Gyan Chand Yadav Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof
US20080089947A1 (en) * 2006-08-18 2008-04-17 Knox Clayton D Calcium Influx Inhibitors in the Treatment of Ischemia
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
ITMI20131485A1 (it) 2012-09-10 2014-03-11 Rivopharm Sa Composizione farmaceutica comprendente lacipidina e processo di preparazione
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
FI81568B (fi) 1990-07-31
DK378085A (da) 1986-02-23
NL193065B (nl) 1998-05-06
JPS6479152A (en) 1989-03-24
LU86047A1 (fr) 1986-02-28
CY1494A (en) 1990-02-16
FI853206L (fi) 1986-02-23
SA91120277B1 (ar) 2006-05-15
NO167142C (no) 1991-10-09
US4801599A (en) 1989-01-31
KR870002073A (ko) 1987-03-28
DE3529997C2 (de) 1996-01-18
NL8502296A (nl) 1986-03-17
LU88267I2 (fr) 1994-02-03
NO167142B (no) 1991-07-01
BG60409B2 (bg) 1995-02-28
JPS6193162A (ja) 1986-05-12
MX159974A (es) 1989-10-17
DK378085D0 (da) 1985-08-20
PH22014A (en) 1988-05-02
PT81000B (pt) 1988-03-03
HU196754B (en) 1989-01-30
GB2164336A (en) 1986-03-19
NL980037I1 (nl) 1999-02-01
FI853206A0 (fi) 1985-08-21
GB2164336B (en) 1988-06-08
CS403091A3 (en) 1992-06-17
DE3529997A1 (de) 1986-03-06
ES552050A0 (es) 1987-09-01
NO1999007I1 (no) 1999-04-23
CA1268180A (fr) 1990-04-24
SE8503888D0 (sv) 1985-08-20
NO853293L (no) 1986-02-24
ES8707932A1 (es) 1987-09-01
AU4657685A (en) 1986-02-27
ES8703839A1 (es) 1987-03-01
ZW13185A1 (en) 1986-03-19
HUT40625A (en) 1987-01-28
IE58486B1 (en) 1993-09-22
SE8503888L (sv) 1986-02-23
DK165949B (da) 1993-02-15
ES8802497A1 (es) 1988-07-01
JPH0686430B2 (ja) 1994-11-02
ES546324A0 (es) 1987-03-01
BE903103A (fr) 1986-02-24
DK165949C (da) 1993-07-05
ES552048A0 (es) 1987-09-01
FR2569402A1 (fr) 1986-02-28
GB8520924D0 (en) 1985-09-25
FR2569402B1 (fr) 1989-09-22
AT394042B (de) 1992-01-27
ES552051A0 (es) 1987-09-01
ES8707931A1 (es) 1987-09-01
JPH0550506B2 (fr) 1993-07-29
GR852016B (fr) 1985-12-19
ATA245485A (de) 1991-07-15
SE459920B (sv) 1989-08-21
NL980037I2 (nl) 1999-03-01
ES8707930A1 (es) 1987-09-01
FI81568C (fi) 1990-11-12
SG40889G (en) 1989-12-22
AU578724B2 (en) 1988-11-03
US5011848A (en) 1991-04-30
PT81000A (en) 1985-09-01
CH666684A5 (de) 1988-08-15
IE852054L (en) 1986-02-22
NL193065C (nl) 1998-09-08
KR920004482B1 (ko) 1992-06-05
ES552049A0 (es) 1988-07-01
SK278327B6 (en) 1996-11-06
NZ212895A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
HK52990A (en) 4-aryl-1, -4- dihydropyridine-3, 5- dicaboxylate derivatives
HUT37409A (en) Light-sensitive compositions and process for the producton of light-sensitive compounds containing /trichlor-methyl/-groups, qpplied as component of these compositions
BR8901097A (pt) Processo para a preparacao de uma composicao biocida
HU9402218D0 (en) Pyridinecarboximidamide compounds, pharmaceutical compositions containing them and process for producing them
NO161564C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
AU647481B2 (en) Hexahydroazepine derivatives, a process for their preparation and pharmaceutical compositions containing them
DK240184D0 (da) Beta-carboline-3-carboxylic acid derivatives and method of preparing the same
ES2000292A6 (es) Procedimiento de obtencion de derivados de 1-(2-fenil)-1h-1,3,4-triazolidin-2,5-diona
DE3785695D1 (en) 1,4-dihydropyridinderivate.
DE3779813D1 (en) 1,4-dihydropyridinderivate.
AU6599186A (en) N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives
AU2977784A (en) Hexahydropyrrolo (2,1-a) isoquinoline derivatives
ATE89818T1 (de) Dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE100083T1 (de) Dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
EP0230474A4 (fr) Derives de bis-dioxopiperazine et compositions de medicaments les contenant.
JO1452B1 (en) Heterocyclic derivatives
AU7384381A (en) Substituted oxadiazoles
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20050820